After Gilead controversy, lawmakers seek details on HHS patent reviews

After Gilead controversy, lawmakers seek details on HHS patent reviews

With eyes on Gilead, lawmakers want details on how HHS reviews possible patent infringement

By ED SILVERMAN

ALEX WONG/GETTY IMAGES

A pair of lawmakers wants more information on how HHS manages patents and licenses for medicines discovered, at least in part, with taxpayer dollars.

READ MORE